Plethysmography Opto-electronic and Asthma
Analysis of the Distribution of Pulmonary Ventilation After Nebulization by Heliox Associated With Positive Expiratory Pressure in Patients Asthmatics Stable.
1 other identifier
interventional
27
1 country
1
Brief Summary
Objective: To assess the influence of nebulization with bronchodilators carried by the heliox coupled to PEP in the distribution of compartimental lung volumes in asmathic adults and to correlate with pulmonary function data. Methods: A controlled randomized trial involving 27 patients divided into four groups: heliox + PEP, oxygen + PEP, heliox and oxygen. After the initial evaluation, it was placing 89 reflective markers attached to the surface of the trunk and images acquired by optoelectronic plethysmography (OEP) of six cameras. Three slow vital capacity maneuvers and quiet breathing regarded as phase control. After the control phase, all patients underwent nebulization with a distribution noninvasive system, semi-closed using 10 drops of Fenoterol Bromide and 20 drops of Ipratropium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Jun 2009
Shorter than P25 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 30, 2013
CompletedFirst Posted
Study publicly available on registry
February 5, 2013
CompletedFebruary 5, 2013
December 1, 2012
Same day
January 30, 2013
February 1, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Distribution of volumes of the rib cage in asthma patients-Plesthysmography opto - electronic (POE).
The markers are meant to reflect the infrared signal emitted by the POE to the sensors, which transform these signals into information about the movement of the chest. In this evaluation method the chest is considered a geometric model divided into three regions - the volume of pulmonary rib cage (Vrp), abdominal rib cage volume (Vra), part of the chest corresponding to the diaphragm, and abdomen (Va), and the overall volume of the chest (Vcw) the total volume of compartments.
5 months
Secondary Outcomes (1)
Lung function in asthmatic subjects
5 mothns
Study Arms (4)
Oxygen
PLACEBO COMPARATORPEEP + Heliox
EXPERIMENTALOxygen + PEEP
EXPERIMENTALHeliox
ACTIVE COMPARATORInterventions
For inhalation of oxygen, we used a noninvasive delivery system, semi - closed (Figure 3) consisting of a non-toxic face mask with two unidirectional valves - inspiratory and expiratory branch - connected to the nebulizer (Airlife Misty Neb, Baxter; Valencia, CA, USA). In the inspiratory branch, a reservoir bag (Hudson RCI, USA) with capacity of 2.5 L was connected, in order to avoid dilution of the gas. This skin was fixed to the patient's face to prevent leakage and to maintain adequate pressurization and improved patient compliance to the PEEP. The nebulizer was fed by a flow of 8 l / min of oxygen.
For inhalation of heliox, we used a noninvasive delivery system, semi - closed consisting of a non-toxic face mask with two unidirectional valves - inspiratory and expiratory branch - connected to the nebulizer (Airlife Misty Neb, Baxter; Valencia, CA, USA). In the inspiratory branch, a reservoir bag (Hudson RCI, USA) with capacity of 2.5 L was connected, in order to avoid dilution of the gas. This skin was fixed to the patient's face to prevent leakage and to maintain adequate pressurization and improved patient compliance to the PEEP. The nebulizer was fed by a 11 l / min of heliox for the heliox group in accordance with a protocol of Hess et al.
PEEP supplied was 10 cm H2O through valve (Vital Signs,Totowa, USA) attached to the expiratory branch.
Eligibility Criteria
You may qualify if:
- The study included individuals diagnosed with moderate to severe asthma with forced expiratory volume in one second (FEV1) \<60% or FEV1 \<60% - 80% predicted;
- showing reversibility of bronchial obstruction after administration of bronchodilators at least 10% in FEV1.
You may not qualify if:
- unable to understand or perform the spirometric maneuver;
- with a history of smoking;
- pulmonary comorbidities as chronic obstructive pulmonary disease (COPD);
- bronchiectasis and tuberculosis sequel;
- hemodynamic instability defined as heart rate (HR) greater than 150 bpm or systolic blood pressure below 90 mmHg or greater than 150mmHg;
- pregnancy and any contraindication to the use of PEEP;
- such as increased work of breathing (acute asthma);
- active hemoptysis;
- acute sinusitis;
- pneumothorax;
- untreated; surgery or facial trauma;
- oral or injury;
- epistaxis;
- nausea and esophageal surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratório de Fisiologia e Fisioterapia cardiorespiratória
Recife, Pernambuco, 50670901, Brazil
Related Publications (2)
Frischknecht-Christensen E, Norregaard O, Dahl R. Treatment of bronchial asthma with terbutaline inhaled by conespacer combined with positive expiratory pressure mask. Chest. 1991 Aug;100(2):317-21. doi: 10.1378/chest.100.2.317.
PMID: 1864100RESULTManthous CA, Hall JB, Caputo MA, Walter J, Klocksieben JM, Schmidt GA, Wood LD. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):310-4. doi: 10.1164/ajrccm.151.2.7842183.
PMID: 7842183RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 30, 2013
First Posted
February 5, 2013
Study Start
June 1, 2009
Primary Completion
June 1, 2009
Study Completion
November 1, 2009
Last Updated
February 5, 2013
Record last verified: 2012-12